Ultroid Technologies has retained Armor Capital Management to provide M&A advisory services on all aspects of acquisitions, sales/divestitures, private equity transactions and finance raising, as Ultroid looks to expand its operations in the US and global markets.
The company’s flagship product is the Ultroid Hemorrhoid Management System, a non-invasive, low cost treatment Hemorrhoidal Disease (HD). Physicians perform the painless, 15 minute procedures in their office, without anesthesia, and experience exceptional patient outcomes.
